Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $252.82 | 25 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $220.00 | 23 | $0 (2017) |
| AbbVie Inc. | $18.48 | 1 | $0 (2023) |
| SANOFI PASTEUR INC. | $14.34 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $18.48 | 1 | AbbVie Inc. ($18.48) |
| 2017 | $234.34 | 24 | Janssen Pharmaceuticals, Inc ($220.00) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/13/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $97.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/14/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $3.63 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/07/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $2.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/19/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $3.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/11/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $3.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/06/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/20/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $4.20 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/20/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $2.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/09/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/25/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $4.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/24/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/19/2017 | SANOFI PASTEUR INC. | MENACTRA (Drug), PENTACEL, FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: VACCINES | ||||||
| 05/16/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/20/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/19/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $3.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/07/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/07/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $2.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/17/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/17/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $6.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/03/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $2.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/23/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $2.51 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/14/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $4.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/02/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $2.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/12/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $2.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 968 | 1,256 | $235,415 | $112,048 |
| 2022 | 20 | 1,423 | 1,853 | $327,460 | $157,114 |
| 2021 | 18 | 1,700 | 2,278 | $396,129 | $194,476 |
| 2020 | 22 | 2,173 | 2,789 | $465,836 | $208,287 |
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 335 | 601 | $128,238 | $48,756 | 38.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 224 | 224 | $43,346 | $28,090 | 64.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $6,866 | $5,356 | 78.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 73 | 74 | $6,876 | $5,316 | 77.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 41 | $11,540 | $5,216 | 45.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 19 | 21 | $9,572 | $4,492 | 46.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 74 | $10,778 | $4,327 | 40.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 79 | 80 | $2,958 | $2,356 | 79.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 14 | 14 | $3,998 | $2,249 | 56.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 14 | $4,886 | $2,210 | 45.2% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 13 | 13 | $2,041 | $1,670 | 81.8% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 14 | 15 | $990.00 | $608.25 | 61.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 19 | 19 | $698.00 | $559.55 | 80.2% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 13 | 13 | $1,040 | $510.51 | 49.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 19 | 20 | $690.00 | $190.40 | 27.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 14 | $898.00 | $141.83 | 15.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 463 | 843 | $174,624 | $66,879 | 38.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 273 | 273 | $51,204 | $34,930 | 68.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 123 | 149 | $21,087 | $9,060 | 43.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 48 | 48 | $13,296 | $7,817 | 58.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 27 | 27 | $8,766 | $7,533 | 85.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 100 | 100 | $8,991 | $6,844 | 76.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 29 | 33 | $14,622 | $6,322 | 43.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 20 | 20 | $5,176 | $3,305 | 63.8% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 19 | 21 | $7,124 | $3,269 | 45.9% |
About Dr. Bruce Davis, M.D
Dr. Bruce Davis, M.D is a Family Medicine healthcare provider based in Stroudsburg, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609825926.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Davis, M.D has received a total of $252.82 in payments from pharmaceutical and medical device companies, with $18.48 received in 2023. These payments were reported across 25 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($252.82).
As a Medicare-enrolled provider, Davis has provided services to 6,264 Medicare beneficiaries, totaling 8,176 services with total Medicare billing of $671,925. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Stroudsburg, PA
- Active Since 05/06/2006
- Last Updated 11/15/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1609825926
Products in Payments
- INVOKANA (Drug) $200.18
- XARELTO (Drug) $19.82
- UBRELVY (Drug) $18.48
- MENACTRA (Drug) $14.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Stroudsburg
Dr. Parvez Memon, M.d, M.D
Family Medicine — Payments: $10,679
Ms. Jacqueline Mcgibbon, Md, MD
Family Medicine — Payments: $813.88
Oliana Ros, M.d, M.D
Family Medicine — Payments: $150.56
John Brinker, D.o, D.O
Family Medicine — Payments: $22.37
Christine Huber, Crnp, CRNP
Family Medicine — Payments: $15.15
Gloria Martin, Womans Health, WOMANS HEALTH
Family Medicine